News
In a rare case of ocular relapse in a patient with chronic lymphocytic leukemia (CLL), the oral Bruton tyrosine kinase inhibitor, Imbruvica (ibrutinib) proved to be a safe and effective treatment, according to a recent study.
“This case represents a rare…